Number of peripheral blood regulatory T cells and lymphocyte activation at 3 months after conversion to mTOR inhibitor therapy.
暂无分享,去创建一个
D. San Segundo | M. Arias | M. López-Hoyos | J. Ruiz | C. Gómez-Alamillo | G. Fernández‐Fresnedo | D. S. Segundo | M. Gonzalez | I. Beares | M. Gago | J. Ruiz-Criado | C. Gómez‐Alamillo | M. González